These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 28238742

  • 1. Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis.
    Guttman-Yassky E, Ungar B, Malik K, Dickstein D, Suprun M, Estrada YD, Xu H, Peng X, Oliva M, Todd D, Labuda T, Suarez-Farinas M, Bissonnette R.
    J Allergy Clin Immunol; 2017 Oct; 140(4):1032-1042.e13. PubMed ID: 28238742
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. DFD-01, a Novel Medium Potency Betamethasone Dipropionate 0.05% Emollient Spray, Demonstrates Similar Efficacy to Augmented Betamethasone Dipropionate 0.05% Lotion for the Treatment of Moderate Plaque Psoriasis.
    Fowler JF, Hebert AA, Sugarman J.
    J Drugs Dermatol; 2016 Feb; 15(2):154-62. PubMed ID: 26885782
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis.
    Jensen JM, Scherer A, Wanke C, Bräutigam M, Bongiovanni S, Letzkus M, Staedtler F, Kehren J, Zuehlsdorf M, Schwarz T, Weichenthal M, Fölster-Holst R, Proksch E.
    Allergy; 2012 Mar; 67(3):413-23. PubMed ID: 22142306
    [Abstract] [Full Text] [Related]

  • 6. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis.
    Jensen JM, Pfeiffer S, Witt M, Bräutigam M, Neumann C, Weichenthal M, Schwarz T, Fölster-Holst R, Proksch E.
    J Allergy Clin Immunol; 2009 May; 123(5):1124-33. PubMed ID: 19410693
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M, Gottlieb A, Pariser D, Caro I, Stewart D, Scott G, Abrams K.
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Improvement in Extensive Moderate Plaque Psoriasis With a Novel Emollient Spray Formulation of Betamethasone Dipropionate 0.05.
    Stein Gold L, Jackson JM, Knuckles ML, Weiss JS.
    J Drugs Dermatol; 2016 Mar; 15(3):334-42. PubMed ID: 26954319
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pimecrolimus: a review.
    Gupta AK, Chow M.
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis.
    Nakahara T, Koga T, Fukagawa S, Uchi H, Furue M.
    J Dermatol; 2004 Jul; 31(7):524-8. PubMed ID: 15492415
    [Abstract] [Full Text] [Related]

  • 17. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ, Frankel A, Sohn A, Lebwohl M.
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [Abstract] [Full Text] [Related]

  • 18. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
    Breneman D, Fleischer AB, Kaplan D, Lebwohl M, Miller B, Pariser D, Rist T, Swinyer L, Liu Y, Foley V.
    J Drugs Dermatol; 2005 Jul; 4(3):330-6. PubMed ID: 15898289
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.